• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘致死人数为何在增加?

Why are deaths from asthma increasing?

作者信息

Sears M R

出版信息

Eur J Respir Dis Suppl. 1986;147:175-81.

PMID:2876911
Abstract

Asthma mortality rates have declined only slowly since 1960, and recently have increased in some countries. Deaths in New Zealand's 5-34 year olds showed a sustained increase from 1977 to 1982. In the western United States, asthma mortality in older subjects increased from 1979 to 1982. In 15-44 year olds in England and Wales, mortality rates for females are now lower than in 1960, but rates for males are not. Current asthma mortality rates for Canadian 5-34 year olds are twice those reported a decade ago. A 2-year national study of all New Zealand patients under the age of 70 whose deaths were certified as due to, or related to, asthma found differences in verified asthma mortality rates among races (Maoris 18.9, Pacific Island Polynesians 9.4, and Europeans 3.4 per 100,000); the higher non-European rates explained 36% of the 'excess' New Zealand mortality compared with England. Errors in certification led to a 13% net overestimate of asthma mortality in both countries, but certification was highly accurate in 5-34 year olds. The increase in asthma mortality in the younger age groups is not an artefact of certification or coding, but is real and substantial. Although factors common to previous studies--poor patient compliance, inadequate assessment and therapy, overreliance on bronchodilators and underuse of corticosteroids, and delays in obtaining help--were frequently recognized, no single cause was found to explain the three-fold greater mortality in New Zealand compared with England.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

自1960年以来,哮喘死亡率仅缓慢下降,最近在一些国家还出现了上升。新西兰5至34岁人群的死亡人数在1977年至1982年期间持续增加。在美国西部,老年患者的哮喘死亡率在1979年至1982年期间有所上升。在英格兰和威尔士的15至44岁人群中,女性的死亡率目前低于1960年,但男性并非如此。加拿大5至34岁人群目前的哮喘死亡率是十年前报告的两倍。一项针对新西兰所有70岁以下因哮喘死亡或与哮喘相关死亡的患者进行的为期两年的全国性研究发现,不同种族(毛利人每10万人中有18.9人、太平洋岛波利尼西亚人每10万人中有9.4人、欧洲人每10万人中有3.4人)经核实的哮喘死亡率存在差异;与英格兰相比,非欧洲人较高的死亡率解释了新西兰“超额”死亡率的36%。认证错误导致两国哮喘死亡率净高估13%,但在5至34岁人群中认证非常准确。年轻年龄组哮喘死亡率的上升并非认证或编码的人为因素,而是真实且显著的。尽管先前研究中常见的因素——患者依从性差、评估和治疗不足、过度依赖支气管扩张剂和皮质类固醇使用不足以及获得帮助延迟——经常被认识到,但没有发现单一原因能解释新西兰与英格兰相比高出三倍的死亡率。(摘要截选至250字)

相似文献

1
Why are deaths from asthma increasing?哮喘致死人数为何在增加?
Eur J Respir Dis Suppl. 1986;147:175-81.
2
Asthma mortality in New Zealand: a two year national study.新西兰的哮喘死亡率:一项为期两年的全国性研究。
N Z Med J. 1985 Apr 24;98(777):271-5.
3
Worldwide trends in asthma mortality.
Bull Int Union Tuberc Lung Dis. 1991 Jun-Sep;66(2-3):79-83.
4
Stabilization of asthma mortality.哮喘死亡率的稳定
Ann Allergy Asthma Immunol. 1997 Apr;78(4):347-54. doi: 10.1016/S1081-1206(10)63195-X.
5
A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001.1990 - 2001年美国哮喘死亡率的多死因分析
J Asthma. 2005 Nov;42(9):757-63. doi: 10.1080/02770900500308189.
6
Trends in mortality from bronchial asthma in Switzerland, 1969-1993.1969 - 1993年瑞士支气管哮喘死亡率趋势
Rev Epidemiol Sante Publique. 1996 Apr;44(2):155-61.
7
Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000.1968年至2000年英格兰和威尔士儿童呼吸系统疾病死亡趋势。
Thorax. 2005 Dec;60(12):1035-8. doi: 10.1136/thx.2005.044750. Epub 2005 Sep 2.
8
Asthma in Scotland: epidemiology and clinical management.苏格兰的哮喘:流行病学与临床管理
Health Bull (Edinb). 1993 Mar;51(2):118-27.
9
Asthma mortality: comparison between New Zealand and England.哮喘死亡率:新西兰与英格兰的比较。
Br Med J (Clin Res Ed). 1986 Nov 22;293(6558):1342-5. doi: 10.1136/bmj.293.6558.1342.
10
[Asthma mortality: consequences for therapy?].[哮喘死亡率:对治疗有何影响?]
Schweiz Med Wochenschr. 1993 Feb 6;123(5):165-9.

引用本文的文献

1
Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study.哮喘缓解药物不适当和过度使用的预测因素:一项基于人群的 16 年研究。
BMC Pulm Med. 2018 Feb 12;18(1):33. doi: 10.1186/s12890-018-0598-4.
2
Characteristics of women exposed and unexposed to environmental tobacco smoke (ETS) in a general population sample of North Italy (Po River Delta epidemiological study).
Eur J Epidemiol. 2001;17(4):363-8. doi: 10.1023/a:1012797315210.
3
Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment.吸入性短效β2受体激动剂在哮喘治疗中的应用:规律治疗与按需治疗
Cochrane Database Syst Rev. 2000;2003(4):CD001285. doi: 10.1002/14651858.CD001285.
4
Epidemiology of deaths from asthma in Pennsylvania, 1978-87.1978 - 1987年宾夕法尼亚州哮喘死亡流行病学
Public Health Rep. 1993 Jan-Feb;108(1):66-9.
5
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.吸入沙丁胺醇、非诺特罗和异丙肾上腺素对心血管及低钾血症的影响。
Thorax. 1989 Feb;44(2):136-40. doi: 10.1136/thx.44.2.136.
6
Mediator and cellular mechanisms in asthma. The Philip Ellman lecture 1990.哮喘中的介质与细胞机制。菲利普·埃尔曼讲座,1990年
J R Coll Physicians Lond. 1990 Oct;24(4):304-12.
7
Prevalence and management of asthma in a London inner city general practice.伦敦市中心一家普通诊所中哮喘的患病率及管理情况
Br J Gen Pract. 1990 May;40(334):197-201.